Brief: Entera Bio Files Patent Applications For Inventions That Optimize Its Platform Technology For Oral Delivery Of Large Molecule Therapeutics
May 5 (Reuters) - Entera Bio Ltd 5DT.F :
* ENTERA BIO FILES PATENT APPLICATIONS FOR INVENTIONS THAT
OPTIMIZE ITS PLATFORM TECHNOLOGY FOR ORAL DELIVERY OF LARGE
MOLECULE THERAPEUTICS
Source text for Eikon: ID:nGNX8gX05h
Further company coverage: 5DT.F
Recent news on Entera Bio
See all newsBrief: Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., As Chief Medical Officer Ahead Of Planned Eb613 Phase 3 Initiation
Corrected: Israel's Entera Bio Q2 net loss widens
NASDAQ RESUMED AT 10:02 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:57 AM
Brief: Entera Bio Announces Pricing Of Oversubscribed $275 Million Private Placement